These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8029796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL.
    Thromb Haemost; 1993 Feb 01; 69(2):130-4. PubMed ID: 8456425
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of thrombin by synthetic hirudin peptides.
    Binnie CG, Erickson BW, Hermans J.
    FEBS Lett; 1990 Sep 17; 270(1-2):85-9. PubMed ID: 2226793
    [Abstract] [Full Text] [Related]

  • 4. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J.
    J Clin Invest; 1990 Aug 17; 86(2):385-91. PubMed ID: 2384594
    [Abstract] [Full Text] [Related]

  • 5. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.
    Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS.
    Circulation; 1994 Oct 17; 90(4):1956-63. PubMed ID: 7923685
    [Abstract] [Full Text] [Related]

  • 6. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M, Fujimori Y, Nakamura S, Kondo Y, Kuroda Y, Oka S, Nakagawa T, Katagiri H, Murata M.
    J Clin Pathol; 2019 Dec 17; 72(12):817-824. PubMed ID: 31366633
    [Abstract] [Full Text] [Related]

  • 7. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH, Sze P, Winant RC, Hudson D, Underhill P, Lazar JB, Olsen C, Almquist R.
    Haemostasis; 1991 Dec 17; 21 Suppl 1():41-8. PubMed ID: 1894196
    [Abstract] [Full Text] [Related]

  • 8. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM, Hoppensteadt D, Koza M, Wallock M, Pifarre R, Fareed J.
    Haemostasis; 1991 Dec 17; 21 Suppl 1():49-63. PubMed ID: 1894197
    [Abstract] [Full Text] [Related]

  • 9. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN, Girardot C, Lecoffre C, Lunven C.
    Thromb Haemost; 1994 Sep 17; 72(3):381-6. PubMed ID: 7855788
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
    Ofosu FA, Fenton JW, Maraganore J, Blajchman MA, Yang X, Smith L, Anvari N, Buchanan MR, Hirsh J.
    Biochem J; 1992 May 01; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
    [Abstract] [Full Text] [Related]

  • 11. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY.
    J Biol Chem; 1990 Dec 25; 265(36):22159-66. PubMed ID: 2266119
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J, Walsmann P.
    Semin Thromb Hemost; 1991 Apr 25; 17(2):94-8. PubMed ID: 1771418
    [Abstract] [Full Text] [Related]

  • 13. Comparison of in vitro and in vivo properties of rhirudin (HBW 023) and a synthetic analogous peptide.
    Römisch J, Diehl KH, Hoffmann D, Krahl-Mateblowski U, Reers M, Stüber W, Pâques EP.
    Haemostasis; 1993 Apr 25; 23(5):249-58. PubMed ID: 8175045
    [Abstract] [Full Text] [Related]

  • 14. Comparison of hirudin and hirudin PA C-terminal fragments and related analogs as antithrombin agents.
    Krstenansky JL, Owen TJ, Yates MT, Mao SJ.
    Thromb Res; 1988 Oct 15; 52(2):137-41. PubMed ID: 3194888
    [Abstract] [Full Text] [Related]

  • 15. Displacement of fibrin-bound thrombin by r-hirudin precludes the use of 131I-r-hirudin for detecting pulmonary emboli in the rabbit.
    Rubens FD, Ross-Ouellet B, Dennie C, Coates G, Kinlough-Rathbone RL, Hatton MW.
    Thromb Haemost; 1994 Aug 15; 72(2):232-8. PubMed ID: 7831658
    [Abstract] [Full Text] [Related]

  • 16. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M, Huisse MG, Krstenansky JL, Bezeaud A, Guillin MC.
    Thromb Haemost; 1991 Sep 02; 66(3):300-5. PubMed ID: 1746000
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T, Rothe M, Dodt J.
    Eur J Biochem; 1991 Jan 01; 195(1):251-6. PubMed ID: 1991472
    [Abstract] [Full Text] [Related]

  • 18. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors.
    Lombardi A, Nastri F, Della Morte R, Rossi A, De Rosa A, Staiano N, Pedone C, Pavone V.
    J Med Chem; 1996 May 10; 39(10):2008-17. PubMed ID: 8642559
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
    De Filippis V, Quarzago D, Vindigni A, Di Cera E, Fontana A.
    Biochemistry; 1998 Sep 29; 37(39):13507-15. PubMed ID: 9753436
    [Abstract] [Full Text] [Related]

  • 20. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM, Chao B, Joseph ML, Jablonski J, Ramachandran KL.
    J Biol Chem; 1989 May 25; 264(15):8692-8. PubMed ID: 2722794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.